Literature DB >> 22790217

Intraplantar injection of linalool reduces paclitaxel-induced acute pain in mice.

Soh Katsuyama1, Hikari Kuwahata, Tomomi Yagi, Yukinaga Kishikawa, Takaaki Komatsu, Tsukasa Sakurada, Hitoshi Nakamura.   

Abstract

Linalool is the principal component of many essential oils known to possess biological activities. We previously reported that intraplantar injection of linalool reduces the nociceptive response as assayed by the capsaicin test. In this study, we sought to determine whether intraplantar injection of linalool could influence the induction of acute pain (allodynia and hyperalgesia) by paclitaxel in mice. Paclitaxel is widely used in cancer chemotherapy for the treatment of solid tumors, but it sometimes induces moderate to severe acute pain. Paclitaxel administered intraperitoneally as a single dose of 5, 10 or 20 mg/kg produced mechanical allodynia and hyperalgesia in mice. Paclitaxel-induced mechanical allodynia and hyperalgesia began 1 day after administration of paclitaxel and resolved within 7 days. Linalool injected into the hindpaw caused a significant reduction in paclitaxel-induced mechanical allodynia and hyperalgesia. Pretreatment with naloxone hydrochloride, an opioid receptor antagonist, or naloxone methiodide, a peripherally acting µ-opioid receptor-preferring antagonist, significantly reversed linalool-induced antiallodynia and antihyperalgesia. Our results provide evidence for the involvement of peripheral opioids in antiallodynia and antihyperalgesia induced by linalool. These results suggest that activation of peripheral opioid receptors may play an important role in reducing paclitaxel-induced mechanical allodynia and hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790217     DOI: 10.2220/biomedres.33.175

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  7 in total

Review 1.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

2.  Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.

Authors:  Willias Masocha
Journal:  Sci Rep       Date:  2014-10-22       Impact factor: 4.379

Review 3.  Analgesic-Like Activity of Essential Oil Constituents: An Update.

Authors:  Rita de Cássia da Silveira E Sá; Tamires Cardoso Lima; Flávio Rogério da Nóbrega; Anna Emmanuela Medeiros de Brito; Damião Pergentino de Sousa
Journal:  Int J Mol Sci       Date:  2017-12-09       Impact factor: 5.923

4.  Evaluation of the Anti-Cancer/Anti-Mutagenic Efficiency of Lavandula officinalis Essential Oil.

Authors:  Maha A Fahmy; Ayman A Farghaly; Entesar E Hassan; Emad M Hassan; Zeinab M Hassan; Khaled Mahmoud; Enayat A Omara
Journal:  Asian Pac J Cancer Prev       Date:  2022-04-01

5.  Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia.

Authors:  Damiana Scuteri; Roberta Cassano; Sonia Trombino; Rossella Russo; Hirokazu Mizoguchi; Chizuko Watanabe; Kengo Hamamura; Soh Katsuyama; Takaaki Komatsu; Luigi Antonio Morrone; Laura Rombolà; Annagrazia Adornetto; Annarita S Laganà; Maria Tiziana Corasaniti; Paolo Tonin; Shinobu Sakurada; Tsukasa Sakurada; Pierluigi Nicotera; Giacinto Bagetta
Journal:  Pharmaceutics       Date:  2021-03-12       Impact factor: 6.321

6.  Antioxidant activity of linalool in patients with carpal tunnel syndrome.

Authors:  Geun-Hye Seol; Purum Kang; Hui Su Lee; Geun Hee Seol
Journal:  BMC Neurol       Date:  2016-02-02       Impact factor: 2.474

Review 7.  Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant.

Authors:  Elaine C D Gonçalves; Gabriela M Baldasso; Maíra A Bicca; Rodrigo S Paes; Raffaele Capasso; Rafael C Dutra
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.